Editas Medicine, Inc.
Engineered Cas9 nucleases
Last updated:
Abstract:
The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.
Status:
Grant
Type:
Utility
Filling date:
19 Aug 2019
Issue date:
24 Aug 2021